Tag: AI in drug development
-
MIT-Takeda Program wraps up with 16 publications, a patent, and nearly two dozen projects completed
When the Takeda Pharmaceutical Co. and the MIT School of Engineering launched their collaboration focused on artificial intelligence in health care and drug development in February 2020, society was on the cusp of a globe-altering pandemic and AI was far from the buzzword it is today. As the programย concludes, the world looks very different. AIย has…
-
When an antibiotic fails: MIT scientists are using AI to target โsleeperโ bacteria
Since the 1970s, modern antibiotic discovery has been experiencing a lull. Now the World Health Organization has declared the antimicrobial resistance crisis as one of the top 10 global public health threats.ย When an infection is treated repeatedly, clinicians run the risk of bacteria becoming resistant to the antibiotics. But why would an infection return…
-
What to do about AI in health?
Before a drug is approved by the U.S. Food and Drug Administration (FDA), it must demonstrate both safety and efficacy. However, the FDA does not require an understanding a drugโs mechanism of action for approval. This acceptance of results without explanation raises the question of whether the “black box” decision-making process of a safe and…